Laura Melado Vidales, M.D., Ph.D.

IVF specialist IVI Middle East

IVI Middle East

Laura Melado Vidales, M.D., Ph.D.

Biography

Dr. Melado is Specialist in Obstetrics, Gynecology and Reproductive Endocrinology/IVF for Health Authority Abu Dhabi (DOH) and Dubai Health Authority (DHA). She completed her Bachelor’s degree in Medicine and Surgery at the University Autónoma in Madrid in 2002, and her residency in Obstetrics and Gynecology at the Hospital Universitario La Paz, Madrid, with a rating of Excellent. She obtained her doctorate degree “cum laude” in 2015 in the Obstetrics and Gynaecology Department of the University Autónoma of Madrid School of Medicine.

As a doctor, she has worked as Ob/Gyn and IVF and Fertility Consultant in Hospital Universitario La Paz in Madrid, Hospital Universitario Quirón Madrid and Clínica Ginefiv. In the Middle East, she worked as Specialist in Al Ain Fertility Center and joined IVI Middle East in 2016, working in Abu Dhabi and Dubai Clinics. She is a member of European Society of Human Reproduction and Embryology (ESHRE), Spanish Board of Obstetrics and Gynecology, Spanish Fertility Society (SEF), and Spanish Society of Obstetrics and Gynecology (SEGO). Her main research is focused in ovarian reserve assessment using anti-Mullerian hormone (AMH), and implications for ovarian stimulation and in predicting oocyte quality and IVF outcome.


Read more

Education and Training

B.Sc. University Autónoma of Madrid, Spain (2002)
Ph.D (Ob/Gyn/Fertility) University Autónoma of Madrid, Spain (2015)
Ob/Gyn Residence Hospital Universitario La Paz, Madrid, Spain (2003-2007)

Publications


  • Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarianhyperstimulation.
    Melado Vidales L, Fernández-Nistal A, Martínez Fernández V, Verdú Merino V, Bruna Catalán I, Bajo Arenas JM.
    Minerva Ginecol, 69(3):225-232, 2017.

  • Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
    Melado Vidales L, Fernández-Nistal A, Martínez Fernández V, Verdú Merino V, Bruna Catalán I, Bajo Arenas JM.
    Minerva Ginecol, 69(2):128-134. 2017.

  • Modified Vecchietti's vaginoplasty with Remeex system in patient with chronic graft-versus-host disease.
    Melado Vidales L, Muñoz Muñiz M, Santisteban Padro J.
    Open Journal of Obstetrics and Gynecology, 2, 85-88, 2012.

  • Homone Therapy: the only Treatment in Patients with hormone-elderly breast carcinoma sentitive unsuitable to surgical Treatment.
    Melado Vidales L, Hernandez Cortes G.
    Chapter 3. In: Cancer in the elderly. Nova Science Publishers, Inc. © 2011.

  • Hormone therapy as first treatment in patients with operable breast cancer.
    Melado Vidales L, Hernandez Cortes G, Muñoz Muñiz M, Santiago Garcia J, Ordás Santo Tomas, J.
    Prog Obstet Gynecol; 52 (1):11-21, 2009.

  • Comparison of the intrauterine system releasing levonorgestrel (Mirena) and endometrial ablation in the treatment of dysfunctional uterine bleeding.
    Melado Vidales L, Monica Novelle G, Alicia Hernandez G, Mar Muñoz M, Juan Ordas ST.
    Rev Chil Obstet Gynecol; 73 (4): 263-267, 2008.


  • Abdominal situs inversus and azygos-IVC continuity.
    Melado Vidales L, Herrero Ruiz B, Rodriguez Gonzalez R, Alvarez Charines E, Herrero de Lucas L, Gonzalez Gonzalez A
    Case report. Prog Obstet Gynecol; 51 (6) :355-9, 2008.

  • Ordás Deep infiltrating endometriosis, case report.
    Melado Vidales L, Hernandez Gutierrez A, Munoz Muniz MM, Thomas J.
    Prog Obstet Gynecol; 50 (10) :609-14, 2007.

  • Naranjo Sancha Fatal anaphylactic shock during the course of a cesarean section.
    Melado Vidales L, Sánchez Hernández MJ, Martos MA Cano, Molina MM Hita, M.
    Prog Obstet Gynecol, 48 Suppl 2:343-345, 2005.


Read more
Close Menu